COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City

Abstract Background To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020-2022) in New York City (NYC). Methods Two hundred and seventy five PWID were recruited from October 2021 to September 2022. A structured questionnaire was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Don C. Des Jarlais (VerfasserIn), Chenziheng Allen Weng (VerfasserIn), Jonathan Feelemyer (VerfasserIn), Courtney McKnight (VerfasserIn)
Format: Buch
Veröffentlicht: BMC, 2023-05-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0b2d77a2515b46cbb0ed69fbe8a5b19f
042 |a dc 
100 1 0 |a Don C. Des Jarlais  |e author 
700 1 0 |a Chenziheng Allen Weng  |e author 
700 1 0 |a Jonathan Feelemyer  |e author 
700 1 0 |a Courtney McKnight  |e author 
245 0 0 |a COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City 
260 |b BMC,   |c 2023-05-01T00:00:00Z. 
500 |a 10.1186/s12954-023-00791-0 
500 |a 1477-7517 
520 |a Abstract Background To examine COVID-19 vaccination and HIV transmission among persons who inject drugs (PWID) during the COVID-19 pandemic (2020-2022) in New York City (NYC). Methods Two hundred and seventy five PWID were recruited from October 2021 to September 2022. A structured questionnaire was used to measure demographics, drug use behaviors, overdose experiences, substance use treatment history, COVID-19 infection, vaccination, and attitudes. Serum samples were collected for HIV, HCV, and SARS-CoV-2 (COVID-19) antibody testing. Results Participants were: 71% male, the mean age was 49 (SD 11), 81% reported at least one COVID-19 immunization, 76% were fully vaccinated and 64% of the unvaccinated had antibodies for COVID-19. Self-reported injection risk behaviors were very low. HIV seroprevalence was 7%. Eighty-nine percent of the HIV seropositive respondents reported knowing they were HIV seropositive and being on antiretroviral therapy prior to the COVID-19 pandemic. There were two likely seroconversions in 518.83 person-years at risk from the March 2020 start of the pandemic to the times of interviews, for an estimated incidence rate of 0.39/100 person-years, 95% Poisson CI 0.05-1.39/100 person-years. Conclusions There is concern that the COVID-19 pandemic disruptions to HIV prevention services and the psychological stress of the pandemic may lead to increased risk behavior and increased HIV transmission. These data indicate adaptive/resilient behaviors in both obtaining COVID-19 vaccination and maintaining a low rate of HIV transmission among this sample of PWID during the first two years of the COVID-19 pandemic in NYC. 
546 |a EN 
690 |a Persons who inject drugs (PWID) 
690 |a New York City 
690 |a HIV 
690 |a Incidence 
690 |a COVID-19 
690 |a Vaccination 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Harm Reduction Journal, Vol 20, Iss 1, Pp 1-10 (2023) 
787 0 |n https://doi.org/10.1186/s12954-023-00791-0 
787 0 |n https://doaj.org/toc/1477-7517 
856 4 1 |u https://doaj.org/article/0b2d77a2515b46cbb0ed69fbe8a5b19f  |z Connect to this object online.